Physician

Deanne Michiko Nakamoto, MD

According to 2025 Medicare claims, Deanne Nakamoto, MD (NPI: 1609073345) practices ophthalmology in the Bremerton-Silverdale-Port Orchard, WA market, with the plurality of this provider's patient population coming from Kitsap, WA. This provider's primary affiliated billing organization is EYE CLINIC OF BREMERTON, INC. P.S. (NPI: 1831228311; TIN: 911013662) and primary practice location at 98383-6000. Nakamoto is affiliated with the Jefferson Accountable Care, LLC (ACO ID: A5275) and PSW ACO (ACO ID: A5323), participating under the MSSP model.

Nakamoto's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 842 traditional Medicare patients, billed 3,997 HCPCS/CPT codes, and received $275,979 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 2,288 prescription claims across 575 beneficiaries totaling $217,641 in drug costs, led by Lumigan (Bimatoprost). 2018 DME data shows 11 claims. Open Payments data shows 5 records totaling $193. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. In contrast, DME billing represents a smaller volume and changed little.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,010	4,610	$430,451
2016	1,023	4,761	$446,371
2017	1,072	4,830	$411,842
2018	1,109	4,979	$408,634
2019	1,112	4,926	$404,744
2020	972	4,010	$333,303
2021	1,013	4,356	$376,603
2022	994	4,057	$322,824
2023	933	3,912	$318,372
2024	842	3,997	$275,979

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	439	2,818	$232,162
2016	464	2,959	$270,805
2017	442	2,787	$267,942
2018	448	2,621	$271,285
2019	435	1,772	$246,048
2020	401	1,439	$203,750
2021	408	1,256	$153,675
2022	439	1,359	$163,230
2023	558	2,266	$240,480
2024	575	2,288	$217,641

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	17	17	$893
2018	11	11	$551
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	533	1,041	$84
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	364	453	$65
92083	Exam of visual field with extended testing	500	539	$43
92133	Imaging of optic nerve	536	548	$25
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	461	774	$13

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Lumigan	Bimatoprost	59	4,473	$40,885
Rhopressa	Netarsudil Mesylate	46	2,690	$27,255
Restasis	Cyclosporine	14	1,080	$20,900
Latanoprost	Latanoprost	637	45,532	$10,224
Prednisolone Acetate	Prednisolone Acetate	169	10,333	$8,698

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	5	$193	Sight Sciences, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Deanne Michiko Nakamoto, MD?

Tedicare shows public-source Medicare data for Deanne Michiko Nakamoto, MD (NPI 1609073345), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Deanne Michiko Nakamoto, MD have ACO affiliation data?

Deanne Michiko Nakamoto, MD is shown with ACO affiliation data for Jefferson Accountable Care, LLC (MSSP, ACO ID A5275) and PSW ACO (MSSP, ACO ID A5323).

What billing organization is linked to Deanne Michiko Nakamoto, MD?

Deanne Michiko Nakamoto, MD is linked to EYE CLINIC OF BREMERTON, INC. P.S. (billing NPI 1831228311) in the available physician profile data.

Does Deanne Michiko Nakamoto, MD have Open Payments data?

Deanne Michiko Nakamoto, MD has 5 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.